Controversial Alzheimer's drug approval could impact other diseases

Nature, Published online: 29 June 2021; doi:10.1038/d41586-021-01763-9

Aducanumab's fast-tracking has researchers both worried and hopeful about the future of drugs for neurodegenerative diseases such as Huntington’s and Parkinson’s.

Comments

Popular posts from this blog

Photographing Silhouettes, Part 2